1. Home
  2. FORM vs RXRX Comparison

FORM vs RXRX Comparison

Compare FORM & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FORM
  • RXRX
  • Stock Information
  • Founded
  • FORM 1993
  • RXRX 2013
  • Country
  • FORM United States
  • RXRX United States
  • Employees
  • FORM N/A
  • RXRX N/A
  • Industry
  • FORM Semiconductors
  • RXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FORM Technology
  • RXRX Health Care
  • Exchange
  • FORM Nasdaq
  • RXRX Nasdaq
  • Market Cap
  • FORM 2.7B
  • RXRX 2.4B
  • IPO Year
  • FORM N/A
  • RXRX 2021
  • Fundamental
  • Price
  • FORM $29.16
  • RXRX $4.94
  • Analyst Decision
  • FORM Buy
  • RXRX Buy
  • Analyst Count
  • FORM 8
  • RXRX 5
  • Target Price
  • FORM $38.14
  • RXRX $7.00
  • AVG Volume (30 Days)
  • FORM 1.1M
  • RXRX 19.6M
  • Earning Date
  • FORM 07-30-2025
  • RXRX 08-05-2025
  • Dividend Yield
  • FORM N/A
  • RXRX N/A
  • EPS Growth
  • FORM N/A
  • RXRX N/A
  • EPS
  • FORM 0.57
  • RXRX N/A
  • Revenue
  • FORM $764,554,000.00
  • RXRX $64,596,000.00
  • Revenue This Year
  • FORM $2.18
  • RXRX $19.96
  • Revenue Next Year
  • FORM $7.14
  • RXRX $61.39
  • P/E Ratio
  • FORM $51.27
  • RXRX N/A
  • Revenue Growth
  • FORM 8.30
  • RXRX 30.14
  • 52 Week Low
  • FORM $22.58
  • RXRX $3.79
  • 52 Week High
  • FORM $51.68
  • RXRX $12.36
  • Technical
  • Relative Strength Index (RSI)
  • FORM 43.28
  • RXRX 39.76
  • Support Level
  • FORM $27.00
  • RXRX $4.72
  • Resistance Level
  • FORM $30.62
  • RXRX $5.84
  • Average True Range (ATR)
  • FORM 1.14
  • RXRX 0.31
  • MACD
  • FORM 0.04
  • RXRX -0.11
  • Stochastic Oscillator
  • FORM 59.67
  • RXRX 17.74

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: